跳至主要内容
临床试验/TCTR20190306006
TCTR20190306006终止不适用

Correlation between fractional flow reserve and myocardial viability as assessed by cardiac magnetic resonance imaging in late-presenting asymptomatic STEMI patients

RCT0 个研究点目标入组 70 人开始时间: 2019年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
RCT
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.Age >18 years
  • 2.All patients between 18-80 years presenting with STEMI who
  • -were not treated within 48 hours after the onset of symptom to 14 days and did not have post MI angina with stable clinical more than 4 days
  • -Failed thrombolytic therapy and did not undergo pharmacoinvasive in 24 hours with stable clinical more than 4 days
  • 3.Angiographic inclusion criteria
  • -At least 50% to 90% diameter stenosis in an IRA on visual estimation of baseline angiography and judged feasible for treatment with PCI by the operator.
  • 4.Willing to participate and able to understand, read and sign the informed consent document before the planned procedure

排除标准

  • 1.Total occlusion of IRA
  • 2.Pregnancy or planning to become pregnant any time after enrolment into this study.
  • 3.Left main stem disease (stenosis > 50%)
  • 4.Known severe cardiac valve dysfunction that will require surgery in the follow-up period.
  • 5.TIMI flow less than 2 of IRA artery.
  • 6.Killip class III or IV at presentation
  • 7.Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
  • 8.Life expectancy of less than one year
  • 9. Inability to tolerate Adenosine
  • 10. Heavily calcified or tortuous vessel where inability to cross the lesion with a pressure wire is expected.
  • 11.Prior history of MI
  • 12. Prior history of revascularization either PCI or CABG

研究者

发起方
RCT

相似试验